Despite the enforcement of an import ban and restrictions, the domestic production of pharmaceutical raw materials has yet to reach a desirable level, a report by Majlis Research Center, the research arm of the Iranian Parliament reads.
The following are some of the notable findings of the report:
Local production accounts for 13.8% or 198 ingredients on the Iranian Drug List.
Add new comment